Evidence for genetic factors in the development and progression of IgA nephropathy

Kidney International

Volumn 57, Issue 5, 2000, Pages 1818-1835

  Hsu, Stephen I Hong ^a,b,c,d   Ramirez, Sylvia B ^a,b,c   Winn, Michelle P ^a,b,c   Bonventre, Joseph V ^a,b,c   Owen, William F ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Chronic renal failure; Familial nephropathy; Glomerulonephritis; Hematuria; Heredity; IgAN

Indexed keywords

DISEASE COURSE; FAMILIAL DISEASE; GENE MAPPING; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW;

EID: 0034098806     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00032.x     Document Type: Article

References (146)

1. 1. BERGER J, HINGLAIS N: Les dépôts intercapillaires d'IgA-IgG. J Urol Nephrol 74:694-695, 1968
2. 2. BERGER J: IgA glomerular deposits in renal disease. Transplant Proc 1:939-944, 1969
3. 3. CLARKSON AR, WOODROFFE AJ, BANNISTER KM, LOMAX-SMITH JD, AARONS I: The syndrome of IgA nephropathy. Clin Nephrol 21:7-14, 1984
4. 4. GALLA JH: IgA nephropathy. Kidney Int 47:377-387, 1995
5. 5. BEUKHOF JR, OCKHUIZEN T, HALIE LM, WESTRA J, BEELEN JM, DONKER AJM, HOEDEMAEKER PJ, VAN DER HEM GK: Subentities within adult primary IgA-nephropathy. Clin Nephrol 22:195-199, 1984
6. 6. EMANCIPATOR SN, GALLO GR, LAMM ME: IgA Nephropathy: Perspectives on pathogenesis and classification. Clin Nephrol 24:161-179, 1985
7. 7. BEUKHOF JR, KARDAUN O, OCKHUIZEN T, VAN DER HEM GK: Kidney survival in IgA nephropathy: Multiple regression analysis of genetically differing subpopulations: Is IgA nephropathy a real disease entity? Semin Nephrol 7:367-369, 1987
8. 8. D'AMICO G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 245:709-727, 1987
9. 9. LEVY M, BERGER J: Worldwide perspective of IgA nephropathy. Am J Kidney Dis 12:340-347, 1988
10. 10. JULIAN BA, WALDO FB, RIFAI A, MESTECKY J: IgA nephropathy, the most common glomerulonephritis worldwide: A neglected disease in the United States? Am J Med 84:129-132, 1988
11. 11. SCHENA FP: A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 89:209-215, 1990
12. 12. WILLIAMS DG: Pathogenesis of idiopathic IgA nephropathy. Pediatr Nephrol 7:303-311, 1993
13. 13. ENDO Y, KANBAYASHI H: Etiology of IgA nephropathy syndrome. Pathol Int 44:1-13, 1994
14. 14. CONSORTIUM TEPKD: The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77:881-894, 1994
15. 15. CONSORTIUM TIPKD: Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 81:289-298, 1995
16. 16. MOCHIZUKI T, WU G, HAYASHI T, XENOPHONTOS SL, VELDHUISEN BJJ, SARIS JJ, REYNOLDS DM, CAI Y, GABOW PA, PIERIDES A, KIMBERLING WJ, BREUNING MH, DELTAS CC, PETERS DJ, SOMLO S: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339-1342, 1996
17. 17. HILDEBRANDT F, OTTO E, RENSING C, NOTHWANG HG, VOLLMER M, ADOLPHS J, HANUSCH H, BRANDIS M: A novel gene encoding an SH3 domain protein is mutated in nephronophthisis type I. Nat Genet 17:149-153, 1997
18. 18. KESTILA M, LENKKERI U, MANNIKKO M, LAMERDIN J, MCCREADY P, PUTAALA H, RUOTSALAINEN V, MORITA T, NISSINEN M, HERVA R, KASHTAN CE, PELTONEN L, HOLMBERG C, OLSEN A, TRYGGVASON K: Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1:575-582, 1998
19. 19. WAKAI K, KAWAMURA T, MATSUO S, HOTTA N, OHNO Y: Risk factors for IgA nephropathy: A case-control study in Japan. Am J Kidney Dis 33:738-745, 1999
20. 20. RAMBAUSEK MH, WALDHERR R, RITZ E: Immunogenetic findings in glomerulonephritis. Kidney Int 43(Suppl 39):S3-S8, 1993
21. 21. MOORE R: MHC gene polymorphism in primary IgA nephropathy. Kidney Int 43(Suppl 39):S9-S12, 1993
22. 22. SCHENA FP: Immunogenetic aspects of primary IgA nephropathy. Kidney Int 48:1998-2013, 1995
23. 23. MACDONALD IM, DUMBLE LJ, KINCAID-SMITH P: HLA and glomerulonephritis, in HLA and Disease, Paris, INSERM, 1976, p 203
24. 24. BERTHOUX FC, GAGNE A, SABATIER JC, LE PETIT JC, MARCELLIN M, MERCIER B, BRIZARD CP: HLA-Bw35 and mesangial IgA glomerulonephritis. N Engl J Med 298:1034-1035, 1978
25. 25. NOEL LH, DESCHAMPS J, JUNGERS P, BACK JF, BUSSON M, SUET C, HORS J, DAUSSETE J: HLA antigen in three types of glomerulonephritis. Clin Immunol Immunopathol 10:19-23, 1978
26. 26. TOLKOFF-RUBIN NE, COSIMI AB, FULLER T, RUBIN RH, COLVIN RB: IgA nephropathy in HLA-identical siblings. Transplantation 26:430-433, 1978
27. 27. SABATIER JC, GENIN C, ASSENAT H, COLON S, DUCRET F, BERTHOUX FC: Mesangial IgA glomerulonephritis in HLA-identical brothers. Clin Nephrol 11:35-38, 1979
28. 28. HIKI Y, KOBAYASHI Y, TATENO S, SADA M, KASHIWAGI N: Strong association of HLA-DR4 with benign IgA nephropathy. Nephron 32:222-226, 1982
29. 29. MOORE RH, HITMAN GA, LUCAS KY, RICHARDS NT, VENNING MC, PAPIHA S, GOODSHIP THJ, FIDLER A, AWAD J, FESTENSTEIN H, CUNNINGHAM J, MARSH FP: HLA DQ region gene polymorphism associated with primary IgA nephropathy. Kidney Int 37:991-995, 1990
30. 30. LEVY M, LESAVRE P: Genetic factors in IgA nephropathy (Berger's disease). Adv Nephrol 21:23-51, 1992
31. 31. BONTROP RE, CARPENTER CB, WALFORD R, SEKIOUCHI S, BIGNON JD, COHEN D: RFLP standardisation report for DQ Beta/Taq I in Immunobiology of HLA, New York, Springer Verlag, 1989, pp 620-622
32. 32. LI PKT, BURNS AP, SO AKL, PUSEY CD, FEEHALLY J, REES AJ: The DQw7 allele at the HLA-DQB locus is associated with susceptibility to IgA nephropathy in Caucasians. Kidney Int 39:961-965, 1991
33. 33. KNIGHT JF, FALK MC, NG G, FANNING GC, ARTLETT CM, ROY LP: IgA nephropathy: Immunogenetic studies of Australian patients, in Contributions in Nephrology, edited by CLARKSON AR, WOODROFFE AJ, Basel, Karger, pp 18-23
34. 34. MOREEN H, HORS J, RØNNINGEN KS: HLA-DQA1 and -DQB1 polymorphism using polymerase chain reaction (PCR) oligotyping, in HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference, edited by TSUJI K, AIZAWA M, SASAZUKI T, Oxford, Oxford University Press, 1991, pp 477-484
35. 35. FENNESSY M, HITMAN GA, MOORE RH, METCALFE K, MEDCRAFT J, SINICO RA, MUSTONEN JT, D'AMICO G: HLA-DQ gene polymorphism in primary IgA nephropathy in three European populations. Kidney Int 49:477-480, 1996
36. 36. RAGUENES O, MERCIER B, CLEDES J, WHEBE B, FEREC C: HLA class II typing and idiopathic IgA nephropathy (IgAN): DQB1 *0301, a possible marker of unfavorable outcome. Tissue Antigens 45:246-249, 1995
37. 37. MARTINETTI M, CUCCIA M, AMOROSO A, BORELLI I, CAPPELLO N, DAIELLI C, D'ALFONSO S, DONDI E, DUCRET F, DUGOUJON JM, HIRATSKA T, LEFRANC MP, LUGER AM, MAZZOLA G, NAITO S, RICHIARDI P, SALVANESCHI L, WALKER REW, ZHANG XM: Idiopathic IgA mesangial nephropathy: An immunogenetic study, in HLA, 1991: Proceedings of the Eleventh International Histocompatibility Workshop und Conference, edited by TSUJI K, AIZAWA M, SASAZUKI T, Oxford, Oxford University Press, pp 749-755
38. 38. LUGER AM, KOMATHIREDDY G, WALKER RE, PANDEY JP, HOFFMAN RW: Molecular and serologic analysis of HLA genes and immunoglobulin allotypes in IgA nephropathy. Autoimmunity 19:1-5, 1994
39. 39. BERTHOUX P, EL DEEB S, BOULHAROUZ R, CECILLON S, LE PETTI J-C, BERTHOUX FC: HLA molecules and genes in primary IgA nephritis with end-stage renal failure, in IgA Nephropathy: Pathogenesis and Treatment, edited by CLARKSON AR, WOODROFFE AJ, Basel, Karger, 1995, pp 24-28
40. 40. LI PKT, POON ASY, LAI KN: Molecular genetics of MHC class II alleles in Chinese patients with IgA nephropathy. Kidney Int 46:185-190, 1994
41. 41. JIN DK, KOHSAKA T, KOO JW, HA IS, CHEONG HI, CHOI Y: Complement 4 locus II gene deletion and DQA1*0301 gene: Genetic risk factors for IgA nephropathy and Henoch-Schönlein nephritis. Nephron 73:390-395, 1996
42. 42. SCOLARI F, AMOROSO A, SAVOLDI S, MAZZOLA G, PRATI E, VALZORIO B, VIOLA BF, NICOLA B, MOVILLI E, SANDRINI M, CAMPANINI M, MAIORCA R: Familial clustering of IgA nephropathy: Further evidence in an Italian population. Am J Kidney Dis 33:857-865, 1999
43. 43. SCHENA FP, MASTROLITTI G, JIRILLO E, MUNNO I, PELLEGRINO N, FRACASSO AR, AVENTAGGIATO L: Increased production of interleukin-2 and IL-2 receptors in IgA nephropathy. Kidney Int 33:875-879, 1989
44. 44. LAI KN, LEUNG JCK, LI PKT, LUI SF: Cytokine production by peripheral blood mononuclear cells in IgA nephropathy. Clin Exp Immunol 85:240-245, 1991
45. 45. NAGASAWA R, MATSUMURA O, MARUYAMA N, MITARAI T, ISODA K: T-cell receptor beta-chain gene polymorphism and the prognosis of IgA nephropathy in Japanese patients. Nephron 70:502-503, 1995
46. 46. LI PKT, POON P, POON ASY, SZETO CC, YU AWY, LAI KN: Association of IgA nephropathy with T-cell receptor constant alpha chain gene polymorphism. Am J Kidney Dis 30:260-264, 1997
47. 47. JARDINE AG: Angiotensin II and glomerulonephritis. J Hypertens 13:487-493, 1995
48. 48. ANDREUCCI VE, GALLIONI M, BRANCACCIO D: ACE inhibitors and progression of chronic renal insufficiency: A contribution of Italian clinical research. J Nephrol 11:105-109, 1998
49. 49. FOGO A, YOSHIDA Y, YARED AI, ICHIKAWA I: Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys. Kidney Int 38:1068-1074, 1990
50. 50. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRIZL P, FLOEGE U, SCHWARTZ SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
51. 51. WOLF G, NEILSON EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3:1531-1540, 1993
52. 52. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
53. 53. SCHUNKERT H: Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease. J Mol Med 75:867-875, 1997
54. 54. VLEMING LJ, VAN DER PIJL JW, LEMKES HHPJ, WESTENDORP RGJ, MAASSEN JA, DAHA MR, VAN ES LA, VAN KOOTEN C: The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. CLin Nephrol 51:133-140, 1999
55. 55. VAN ESSEN GG, RENSMA PL, DE ZEEUW D, SLUITER WJ, SCHEFFER H, APPERLOO AJ, DE JONG PE: Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 347:94-95, 1996
56. 56. MCLAUGHLIN KJ, HARDEN PN, UEDA S, BOULTON-JONES JM,CONNELL JMC, JARDINE AG: The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases. Hypertension 28:912-915, 1996
57. 57. BABOOLAL K, RAVINE D, DANIELS J, WILLIAMS N, HOLMANS P, COLES GA, WILLIAMS JD: Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 52:607-613, 1997
58. 58. HARDEN PN, GEDDES C, ROWE PA, MCILROY JH, BOULTON-JONES M, RODGER RSC, JUNOR BJR, BRIGGS JD, CONNELL JMC, JARDINE AG: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345:1540-1542, 1995
59. 59. YOSHIDA H, MITARAI T, KAWAMUKA T, KITAJIMA T, MIYAZAKI Y, NAGASAWA R, KAWAGUCHI Y, KUBO H, ICHIKAWA I, SAKAI O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169, 1995
60. 60. FUKUSHIMA T, NOMURA S, KAWAI S, OSAWA G: ACE genotype and progression of IgA nephropathy. Lancet 346:571-572, 1995
61. 61. SCHMIDT S, STIER E, HARTUNG R, STEIN G, BAHNISHCE J, WOODROFFE AJ, CLARKSON AR, PONTICELLI C, CAMPISE M, MAYER G, GANTEN DE, RITZ E: No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulo-nephritis. Am J Kidney Dis 26:727-731, 1995
62. 62. HUNLEY TE, JULIAN BA, PHILLIPS JA III, SUMMAR ML, YOSHIDA H, HORN RG, BROWN NJ, FOGO A, ICHIKAWA I, KON V: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577, 1996
63. 63. PEI Y, SHOLEY J, THAI K, SUZUKI M, CATTRAN D: Association of angiotensinogen gene T235 variant with progression of immunoglobulin A nephropathy in Caucasian patients. J Clin Invest 100:814-820, 1997
64. 64. TANAKA R, IIJMA K, MURAKAMI R, KOIDE M, NAKAMURA H, YOSHIKAWA N: ACE gene polymorphism in childhood IgA nephropathy: Association with clinicopathologic findings. Am J Kidney Dis 31:774-779, 1998
65. 65. STRATTA P, CANAVESE C, CICCONE C, BAROLO S, DALL'OMO AM, FASANO ME, MAZZOLA G, BERUTTI S, FOP F, CURTONI ES, PICCOLI G: Angiotensin I-converting enzyme genotype significantly affects progression of IgA glomerulonephritis in an Italian population. Am J Kidney Dis 33:1071-1079, 1999
66. 66. BLOEM LJ, MANATUNGA AK, PRATT JH: Racial difference in the relationship of the angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 27:62-66, 1996
67. 67. FUJIMURA T, YOKOTA M, KATO S, HIRAYAM H, TSUNEKAWA A, INAGAKI H, TAKATSU F, NAKASHIMA N, YAMADA Y: Lack of association of angiotensin converting enzyme gene polymorphism or serum enzyme activity with coronary artery disease in Japanese subjects. Am J Hypertens 10:1384-1390, 1997
68. 68. LINDPAINTER K, PFEFFER MA, KREUTZ R, STAMPFER MJ, GRODSTEIN F, LAMOTTE F, MURING J, HENNEKENS CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332: 706-711, 1995
69. 69. BONNARDEAUX A, DAVIES E, JEUNEMAITRE X, FERY I, CHARRU A, CLAUSER E, TIRET L, CAMBIEN F, CORVOL P, SOUBRIER F: Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24:63-69, 1994
70. 70. KATSUYA T, KOIKE G, YEE TW, SHARPE N, JACKSON R, NORTON R, HORIUCHI M, PRATI R, DZAU V, MACMAHON S: Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 345:1600-1603, 1995
71. 71. SINNIAH R, PWEE HS, LIM CH: Glomerular lesions in asymptomatic microscopic hematuria discovered on routine medical examination. Clin Nephrol 5:216-228, 1976
72. 72. SINNIAH R, LAW CH, PWEE HS: Glomerular lesions in patients with asymptomatic persistent and orthostatic proteinuria discovered on routine medical examination. Clin Nephrol 7:1-14, 1977
73. 73. SINNIAH R: Occurrence of mesangial IgA and IgM deposits in a control necropsy population. J Clin Pathol 36:276-279, 1983
74. 74. FREEDMAN BI, SOUCIE JM, MCCLELLAN WM: Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol 8:1942-1945, 1997
75. 75. GALLA JH, KOHAUT EC, ALEXANDER R, MESTECKY J: Racial difference in the prevalence of IgA-associated nephropathies. Lancet 2:522, 1984
76. 76. JENNETTE JC, WALL SD, WILMAN AS: Low incidence of IgA nephropathy in blacks. Kidney Int 28:944-950, 1985
77. 77. MONTOLIU J, DARNELL A, TORRAS A, ERCILLA G, VALLES M, REVERT J: Familial IgA nephropathy: Report of two cases and brief review of the literature. Arch Intern Med 140:1374-1375, 1980
78. 78. MILLET VG, PALACIOS JJN, RUANO RO, GUZMAN AB, SARRAGA GU, CARLES CP, MONTALBAN MA, RODICTO JL: Familial and hereditary mesangial glomerulonephritis with IgA deposits. Med Clin (Barc) 76:1-7, 1981
79. 79. NOMOTO Y, ENDO M, MIURA M, SUGA T, TOMINO Y, SAKAI H, NOSE Y, TSUJI K: IgA nephropathy associated with HLA-DR4 antigen. Am J Med 4:184-187, 1984
80. 80. MIURA M, TOMINO Y, YAGAME M, SUGA T, ENDOH M, NOMOTO Y, SAKAI H: Siblings with IgA nephropathy and diffuse proliferative glomerulonephritis (PGN) associated with identical HL-A antigens. Tokai J Exp Clin Med 11:323-327, 1986
81. 81. BRENSILVER JM, MALLAT S, SCHOLES J, MCCABE R: Recurrent IgA nephropathy in living-related donor transplantation: Recurrence or transmission of familial disease? Am J Kidney Dis 12:147-151, 1988
82. 82. GRCEVSKA L, POLENAKOVI M, KOLEVSKI P, STAVRIC D: IgA nephropathy in two HLA-identical brothers and acute, diffuse proliferative glomerulonephritis in the third, HLA-different brother. Nephron 61:479-480, 1992
83. 83. MASUDA J, SHIIKI H, FUJII Y, DOHI K, HARADA A: Identical twin sisters with IgA nephropathy. Nippon Jinzo Gakkai Shi 38:52-56, 1996
84. 84. LEVY M: Familial cases of Berger's disease or of Berger's disease and Henoch-Schönlein purpura: French cooperative group of the Society of Nephrology. Nephrologie 10:175-182, 1989
85. 85. KABASKAL C, KESKINOGLU A, MIR S, BASDEMIR G: IgA nephropathy occurring in two siblings of three families. Turk J Pediatr 39:395-401, 1997
86. 86. JULIAN BA, QUGGINS PA, THOMPSON JS, WOODFORD SY, GLEASON K, WYATT RJ: Familial IgA nephropathy: Evidence of an inherited mechanism of disease. N Engl J Med 312:202-208, 1985
87. 87. SPEER MC: Basic concepts in genetics, in Approaches to Gene Mapping in Complex Human Diseases, edited by HAINES JL, PERICAK-VANCE MA, New York, Wiley-Liss, 1998, pp 17-52
88. 88. HOY WE, SMITH SM, HUGHSON MD, MEGILL DM: Mesangial proliferative glomerulonephritis in Southwestern American Indians. Transplant Proc 21:3909-3912, 1989
89. 89. WOOLF CM, DUKEPOO FC: Hopi Indians, inbreeding, and albinism. Science 164:30-37, 1969
90. 90. HOY WE, MEGILL DM: End-stage renal disease in Southwestern native Americans, with special focus on the Zuni and Navajo Indians. Transplant Proc 21:3906-3908, 1989
91. 91. HUGHSON MD, MEGILL DM, SMITH SM, TUNG KSK, MILLER G. HOY WE: Mesangiopathic glomerulonephritis in Zuni (New Mexico) Indians. Arch Pathol Lab Med 113:148-157, 1989
92. 92. SEPANDJ F, MCFARLANE C, TRILLO A: Nephrotic syndrome secondary to primary immunoglobulin-G mesangioproliferative glomerulonephritis. Nephrol Dial Transplant 13:1889-1890, 1998
93. 93. CUHEN AH, BORDER WA, GLASSOCK RJ: Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest 38:610-619, 1978
94. 94. O'CONNELL PJ, IBELS LS, THOMAS MA, HARRIS M, ECKSTEIN RP: Familial IgA nephropathy: A study of renal disease in an Aboriginal family. Aust N Z J Med 17:27-33, 1987
95. 95. SMITH SM, HOY WE: Frequent association of mesangial glomerulonephritis and alcohol abuse: A study of 3 ethnic groups. Mod Pathol 2:138-143, 1989
96. 96. GESSLER M, SIMOLA KO, BRUNS GA: Cloning of breakpoints of a chromosome translocation identifies the AN2 locus. Science 244:1575-1578, 1989
97. 97. GESSLER M, POUSTKA A, CAVENEE W, NEVE RL, ORKIN SH, BRUN GA: Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778, 1990
98. 98. PFLLETIER J, BRUENING W, LI FP, HABER DA, GLASER T, HOUSMAN DE: WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 353:431-434, 1991
99. 99. SCHWARTZ F, EISENMAN R, KNOLL J, GESSLER M, GRUNS G: cDNA sequence, genomic organization, and evolutionary conservation of a novel gene from the WAGR region. Genomics 29:526-532, 1995
100. 100. CHAHIN J, ORTIZ A, MENDEZ L, GALLEGO E, GARCIA-PEREZ J, GARCIA-CASTRO G, JULIAN BA, EGIDO J: Familial IgA nephropathy associated with bilateral sensorineural deafness. Am J Kidney Dis 19:592-596, 1992
101. 101. TAMAGAWA Y, KITAMURA K, ISHIDA T, ISHIKAWA K, TANAKA H, TSUJI S, NISHIZAWA M: A gene for a dominant form of nonsyndromic sensorineural deafness (DFNA11) maps within the region containing the DFNB2 recessive deafness gene. Hum Mol Genet 5:849-852, 1996
102. 102. LALWANI AK, BRISTER JR, FEN J, GRUNDFAST KM, PIKUS AT, PLOPLIS B, SAN AGUSTIN J, SKARKA H, WILROX ER: A new nonsyndromic X-linked sensorineural hearing impairment linked to Xp21.2. Am J Hum Genet 55:685-694, 1994
103. 103. FITZSIMMONS JS, WAISON AR, MELLOR D, GUILBERT PR: Familial spastic paraplegia, bilateral sensorineural deafness, and intellectual retardation associated with progressive nephropathy. J Med Genet 25:168-172, 1988
104. 104. KOBAYASHI H, GARCIA CA, ALFONSO G, MARKS HG, HOFFMAN EP: Molecular genetics of familial spastic paraplegia: A multitude of responsible genes. J Neurol Sci 137:131-138, 1996
105. 105. IMAI H, NAKAMOTO Y, ASAKURA K, MIKI K, YASUDA T, MIURA AB: Spontaneous glomerular TgA deposition in ddY mice: An animal model of IgA nephritis. Kidney Int 27:756-761, 1985
106. 106. PORTIS JL, COE JE: Deposition of IgA in renal glomeruli of mink affected with Aleutian disease. Am J Pathol 96:227-236, 1979
107. 107. CHEN A, SHEU LF, CHOU WY, TSAI SC, CHANG DM, LIANG SC, LIN FG, LEE WH: Interleukin-1 receptor antagonist modulates the progression of a spontaneously occurring IgA nephropathy in mice. Am J Kidney Dis 30:693-702, 1997
108. 108. WAKUI H, IMAI H, NAKAMOTO Y, KOBAYASHI R, ITOH H, MIURA AB: Antihistone autoantibodies in ddY mice, an animal model for spontaneous IgA nephritis. Clin Immunol Immunopathol 52: 248-256, 1989
109. 109. MIYAWAKI S, MUSO E, TAKEUCHI E, MATSUSHIMA H, SHIBATA Y, SASAYAMA S, YOSHIDA H: Selective breeding for high serum IgA levels from noninbred ddY mice: Isolation of a strain with an early onset of glomerular IgA deposition. Nephron 76:201-207, 1997
110. 110. TAKEUCHI E, DOI T, SHIMADA T, MUSO E, MARUYAMA N, YOSHIDA H: Retroviral gp70 antigen in spontaneous mesangial glomerulonephritis of ddY mice. Kidney Int 35:638-646, 1989
111. 111. KAWAGUCHI S: Immunopathological study of glomerular IgA deposition in ddY mice. Acta Pathol Jpn 38:1-10, 1988
112. 112. Muso E, YOSHIDA H, TAKEUCHI E, SHIMADA T, YASHIRO M, SUGIYAMA T: Pathogenic role of polyclonal and polymeric IgA in a murine model of mesangial proliferative glomerulonephritis with IgA deposition. Clin Exp Immunol 84:459-465, 1991
113. 113. MONTEIRO RC, HALBWACHS-MECARELLI L, ROQUE-BARREIRA MC, NOEL L-H, BERGER J, LESAVRE P: Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 28:666-671, 1985
114. 114. NAGASAWA R, MITARAI T, UISUNOMIYA Y, YOSHIDA H, KITAMURA M, YAMURA W, MARUYAMA N, ISODA K, SAKAI O: Neonatal thymectomy diminished renal IgA deposition in IgA nephropathy-prone ddY mice. Nephron 66:326-332, 1994
115. 115. TOMINO Y, SHIMIZU M, KOIDE H, ABE M, SHIRAI T: Effect of monoclonal antibody CD4 on glomerulonephritis of ddY mice, a spontaneous animal model of IgA nephropathy. Am J Kidney Dis 21:427-432, 1993
116. 116. SHIMAMINE R, SHIBATA R, OZONO Y, HARADA T, TAGUCHI T, HARA K, KONO S: Anti-CD8 monoclonal antibody protects against spontaneous IgA nephropathy in ddY mice. Nephron 78:310-318, 1998
117. 117. NAGASAWA R, TAKAHASHI T, MITARAI T: Polymophism of T cell receptor genes and hyper-production of cytokines: Their possible contribution to the pathogenesis of IgA nephropathy in ddY mouse. Nippon Rinsho 50:3051-3055, 1992
118. 118. IMASAWA T, UTSUNOMIYA Y, KAWAMURA T, NAGASAWA R, MARUYAMA N, SAKAI O: Evidence suggesting the involvement of hematopoietic stem cells in the pathogenesis of IgA nephropathy. Biochem Biophys Res Commun 249:605-611, 1998
119. 119. GESUOLDO L, PINZANI M, FLORIANO JJ, HASSAN MO, NAGY NU, SCHENA FP, EMANCIPATOR SN, ABBOUD HE: Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest 65:160-167, 1991
120. 120. NIEMIR ZI, STEIN H, NORONHA IL, KRÜGER C, ANDRASSY K, RITZ E, WALDHERR R: PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48:1530-1541, 1995
121. 121. TANIGUCHI Y, YORIOKA N, ODA H, YAMAKIDO M: Platelet-derived growth factor, interleukin (IL)-1β, IL-6, IL-6R and tumor necrosis factor-α in IgA nephropathy. An immunohistochemical study. Nephron 74:652-660, 1996
122. 122. NAKAMURA T, EBIHARA I, FUKUI M, TOMINO Y, KOIDE H: Effects of a specific endothelin receptor A antagonist on glomerulonephritis of ddY mice with IgA nephropathy. Nephron 72:454-460, 1996
123. 123. STEIN-OAKLEY AN, MAGUIRE JA, DOWLING J, PERRY G, THOMSON NM: Altered expression of fibrogenic growth factors in IgA nephropathy and focal and segmental glomerulosclerosis. Kidney Int 51:195-204, 1997
124. 124. TSUKASA N, EBIHARA I, NAGAOKA I, TOMINO Y, KOIDE H: Renal platelet-derived growth factor gene expression in NZB/W F1 mice with lupus and ddY mice with IgA nephropathy. Clin Immunol Immunopathol 63:173-181, 1992
125. 125. YE XF, YORIOKA N, ODA H, TANIGUCHI Y, YAMAKIDO M: Role of transforming growth factor-β1 and -β2 in ddY mouse. J Int Med Res 25:141-154, 1997
126. 126. TOMINO Y, NAKAMURA T, EBIHARA I, FUNABIKI K, YAGUCHI Y, SHIMIZU M, SHIRATO I, KOIDE H: Altered steady-state levels of mRNA coding for extracellular matrices in renal tissues of ddY mice, an animal model for IgA nephropathy. J Clin Lab Anal 5:106-113, 1991
127. 127. MUSO E, YOSHIDA H, TAKEUCHI E, YASHIRO M, MATSUSHIMA H, OYAMA A, SUYAMA K, KAWAMURA T, KAMATA T, MIYAWAKI S, IZUI S, SASAYAMA S: Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice. Kidney Int 50:1946-1957, 1996
128. 128. TSUSHIMA Y, TOMINO Y, OHMURA H, TAKEUCHI K, KURAMOTO T, SHIRATO I, KOIDE H: IgA deposits might not influence the production of extracellular matrix in glomeruli of ddY mice, a spontaneous animal model for IgA nephropathy. Nephron 66:81-86, 1994
129. 129. CHEN A, CHEN WP, SHEU LF, LIN CY: Pathogenesis of IgA nephropathy: In vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J Pathol 173:119-126, 1994
130. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 83:708-712, 1989
131. 131. ORISIO S, BENIGNI A, BRUZZI I, CORNA D, PERICO N, ZOJA C, BENATTI L, REMUZZI G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 43:354-358, 1993
132. 132. MATHIS BJ, KIM SH, CALABRESE MH, SEIDMAN JG, SEIDMAN CE, POLLACK MR: A locus for inherited focal segmental glomerulosclerosis maps to chromosome 19q13. Kidney Int 53:282-286, 1998
133. 133. WINN MPPJ, CONLON PJKL, LYNN KLDN, HOWELL DNBD, SLOTTERBECK BD, SMITH AH, GRAHAM FL, BEMBER MB, QUARLES LD, PERICAK-VANCE MA, VANCE JM: Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics 58:113-120, 1999
134. 134. WINN MP, CONLON PJ, LYNN KL, HOWELL DN, GROSS DA, ROGALA AR, SMITH AH, GRAHAM FL, BEMBE M, QUARLES LD, PERICAK-VANCE MA, VANCE JM: Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. Kidney Int 55:1241-1246, 1999
135. 135. SCHILDKRAUT JM: Examining complex genetic interactions, in Approaches to Gene Mapping in Complex Human Diseases, edited by HAINES JL, PERICAK-VANCE MA, New York, Wiley-Liss, 1998, pp 379-410
136. 136. GOLDGAR DE: Sib pair analysis, in Approaches to Gene Mapping in Complex Human Diseases, edited by HAINES JL, PERICAK-VANCE MA, New York, Wiley-Liss, 1998, pp 273-304
137. 137. HAINES JL: Affected relative pair analysis, in Approaches to Gene Mapping in Complex Human Diseases, edited by HAINES JL, PERICAK-VANCE MA, New York, Wiley-Liss, 1998, pp 305-322
138. 138. CHENG IKP, CHAN K-W, CHAN M-K: Mesangial IgA nephropathy with steroid-responsive nephrotic syndrome: Disappearance of mesangial IgA deposits following steroid-induced remission. Am J Kidney Dis 14:361-364, 1989
139. 139. YOSHIKAWA N, IIJIMA K, MATSUYAMA S, SUZUKI J, KAMEDA A, OKADA S, NAKAMURA H: Repeat renal biopsy in children with IgA nephropathy. Clin Nephrol 33:160-167, 1990
140. 140. VANGELISTA A, FRASCÀ GM, MONDINI S, BONOMINI V: Idiopathic IgA mesangial nephropathy: Immunohistological features. Contrib Nephrol 40:167-173, 1984
141. 141. JULIAN BA, CANNON VR, WALDO FB, EGIDO J: Macroscopic hematuria and proteinuria preceding renal IgA deposition in patients with IgA nephropathy. Am J Kidney Dis 17:472-479, 1991
142. 142. ZHENG F, KUNDU GC, ZHANG Z, WARD J, DEMAYO F, MUKHERJEE AB: Uteroglobulin is essential in preventing immunoglobulin A nephropathy in mice. Nat Med 5:1018-1025, 1999
143. 143. ZHANG Z, KUNDU GC, YUAN CJ, WARD JM, LEE EJ, DEMAYO F, WESTPHAL H, MUKHERJEE AB: Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin. Science 276:1408-1412, 1997
144. 144. TOMANA M, NOVAK J, JULILAN BA, MATOUSOVIC K, KONECNY K, MESTECKY J: Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104:73-81, 1999
145. 145. ALLEN AC, BAILEY EM, BARRATT J, BUCK KS, FEEHALLY J: analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol 10:1763-1771, 1999
146. 146. SPIELMAN RS, MCGINNIS RE, EWENS WJ: Transmission test for linkage dysequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516, 1993